Literature DB >> 9857095

Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method.

R H Smith1, W L Jorgensen, J Tirado-Rives, M L Lamb, P A Janssen, C J Michejda, M B Kroeger Smith.   

Abstract

Monte Carlo (MC) simulations in combination with a linear response approach were used to estimate the free energies of binding for a series of 12 TIBO nonnucleoside inhibitors of HIV-1 reverse transcriptase. Separate correlations were made for the R6 and S6 absolute conformations of the inhibitors, as well as for the analogous N6-monoprotonated species. Models based upon the neutral unbound inhibitors produced overall better fits to experimental values than did those using the protonated unbound inhibitors, with only slight differences between the neutral R6 and S6 cases. The best results were obtained with a three-parameter linear response equation containing van der Waals (alpha), electrostatic (beta), and solvent accessible surface area (SASA, gamma) terms. The averaged (R6 and S6) rms error was approximately 0.88 kcal/mol for the observed range of 4.06 kcal/mol in inhibitor activities. The averaged values of alpha, beta, and gamma were -0.150, 0.114, and 0. 0286, respectively. Omission of the alpha term gave beta 0.152 and gamma 0.022 with a rms of 0.92. The unweighted van der Waals components were found to be highly attractive but failed to correlate well across the series of inhibitors. Contrastingly, while the electrostatic components are all repulsive, they show a direct correlation with inhibitor activity as measured by DeltaGbinding. The role of gamma is primarily to produce an overall negative binding energy, and it can effectively be replaced with a negative constant. During the MC simulations of the unbound solvated inhibitors, the R6 and S6 absolute conformations do not interconvert due to the formation of a favorable hydrogen bond to solvent. In the complex, however, interconversion of these conformations of the inhibitor is observed during the course of the simulations, a phenomenon which is apparently not observed in the crystalline state of the complex. Hydrogen bonding of the inhibitor to the backbone NH of K101 and the lack of such an interaction with the C=O of K101 or with solvent correlate with enhanced activity, as does the ability to assume a number of different orientations of the inhibitor dimethylallyl moiety with respect to residues Y181 and Y188 while retaining contact with W229. Overall, the use of a combination of MC simulation with a linear response method shows promise as a relatively rapid means of estimating inhibitor activities. This approach should be useful in the preliminary evaluation of potential modifications to known inhibitors to enhance activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857095     DOI: 10.1021/jm9804174

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.

Authors:  Vigneshwaran Namasivayam; Murugesan Vanangamudi; Victor G Kramer; Sonali Kurup; Peng Zhan; Xinyong Liu; Jacob Kongsted; Siddappa N Byrareddy
Journal:  J Med Chem       Date:  2018-12-27       Impact factor: 7.446

2.  Minimalist explicit solvation models for surface loops in proteins.

Authors:  Ronald P White; Hagai Meirovitch
Journal:  J Chem Theory Comput       Date:  2006       Impact factor: 6.006

3.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

4.  The role of aspartic acid 143 in E. coli tRNA-guanine transglycosylase: insights from mutagenesis studies and computational modeling.

Authors:  Katherine Abold Todorov; Xiao-Jian Tan; Susanne T Nonekowski; George A Garcia; Heather A Carlson
Journal:  Biophys J       Date:  2005-06-10       Impact factor: 4.033

5.  Multi-Site λ-dynamics for simulated Structure-Activity Relationship studies.

Authors:  Jennifer L Knight; Charles L Brooks
Journal:  J Chem Theory Comput       Date:  2011-09-13       Impact factor: 6.006

6.  Molecular dynamics and free energy studies of chirality specificity effects on aminobenzo[a]quinolizine inhibitors binding to DPP-IV.

Authors:  Cui Wei; Liang Desheng; Gao Jian; Luo Fang; Geng Lingling; Ji Mingjuan
Journal:  J Mol Model       Date:  2012-11-15       Impact factor: 1.810

7.  Calculation of binding affinities of HIV-1 RT and beta-secretase inhibitors using the linear interaction energy method with explicit and continuum solvation approaches.

Authors:  Niall J English
Journal:  J Mol Model       Date:  2007-08-10       Impact factor: 1.810

8.  Validating CHARMM parameters and exploring charge distribution rules in structure-based drug design.

Authors:  Jennifer L Knight; Charles L Brooks
Journal:  J Chem Theory Comput       Date:  2009       Impact factor: 6.006

9.  Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.

Authors:  R Pouplana; J J Lozano; C Pérez; J Ruiz
Journal:  J Comput Aided Mol Des       Date:  2002-10       Impact factor: 3.686

10.  Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum.

Authors:  Anthony N Hodder; Alexander G Maier; Melanie Rug; Monica Brown; Mirja Hommel; Ivan Pantic; Marina Puig-de-Morales-Marinkovic; Brian Smith; Tony Triglia; James Beeson; Alan F Cowman
Journal:  Mol Microbiol       Date:  2008-11-05       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.